Strategic expansion BGBx has grown through acquisitions and executive hires, indicating a strategy of expanding capabilities and market reach. Tailor outreach to explore integrated solutions that combine consulting, communications, and digital capabilities for pharmaceutical and life science clients undergoing growth or portfolio expansion.

Leadership focus Recent leadership appointments including Chief Client Officer and Chief Executive Officer suggest emphasis on client engagement, retention, and strategic account development. Target high-potential pharma brands and patient services programs that require enhanced client experience and cross-functional support.

Full-stack capability BGBx combines consulting, science, creativity, data, technology, and digital capabilities. Sell end-to-end programs spanning strategy, lifecycle marketing, market access, and patient services to position BGBx as a one-stop partner for product launches and lifecycle management.

Data and tech leverage The tech stack includes Looker, Qlik, Salesforce, Power Platform, and collaboration tools, signaling strong data analytics and modern operational capabilities. Propose data-driven marketing and KPI-focused campaigns, leveraging analytics to demonstrate impact and ROI for pharmaceutical brands.

M&A and capability build Recent acquisition of Hayden Consulting Group and prior Kx Advisors integration show a willingness to expand capabilities in Market Access and patient services. Pitch complementary services that align with market access, patient support programs, and regulatory considerations to win broader, longer-term engagements.